ATYR PHARMA INC - COM NEW (LIFE)

Historical Portfolio Holders from Q2 2019 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	41.8 M	$81.4 M	+$1.62 M	6.24 K	14.6 K	$1.95	54
2023 Q4	41.2 M	$58.1 M	+$3.55 M	705	987	$1.41	45
2023 Q3	37.1 M	$58.7 M	+$2.05 M	5.53 K	29.2 K	$1.58	41
2023 Q2	35.7 M	$77 M	+$2.32 M	148 K	73.7 K	$2.16	41
2023 Q1	34.7 M	$72.8 M	+$35.3 M	6.72 K	13.9 K	$2.10	37
2022 Q4	18.4 M	$40.2 M	-$2.08 M	77.4 K	6.35 K	$2.19	35
2022 Q3	19 M	$57 M	+$782 K	295 K	56 K	$3.00	31
2022 Q2	18.8 M	$53.1 M	-$3.1 M	387 K	38 K	$2.83	35
2022 Q1	19.6 M	$105 M	-$6.16 M	984 K	345 K	$5.35	39
2021 Q4	20.5 M	$153 M	+$3.92 M	588 K	574 K	$7.47	46
2021 Q3	18.8 M	$171 M	+$109 M	2.95 M	7.58 M	$9.08	40
2021 Q2	6.79 M	$33.1 M	+$4.92 M		71 K	$4.88	23
2021 Q1	5.78 M	$25.7 M	+$195 K			$4.45	19
2020 Q4	5.76 M	$22.4 M	-$373 K			$3.88	18
2020 Q3	5.63 M	$18.2 M	+$464 K			$3.23	19
2020 Q2	5.47 M	$24.3 M	+$1.6 M			$4.44	21
2020 Q1	5.11 M	$14.3 M	+$9.33 M			$2.80	21
2019 Q4	1.79 M	$7.48 M	+$297 K			$4.17	13
2019 Q3	1.72 M	$6.01 M	+$4.15 M			$3.50	13
2019 Q2	530 K	$193 K	+$193 K			$0.36	5